
Regulation Whiplash: FDA’s Game, Changer: The ‘Plausible Mechanism’ Pathway and What It Means for Rare, Disease Therapies
When a mother in Bengaluru posted a tearful message after her child with an ultra, rare genetic disorder gained access to a customised gene therapy approved via the Food and

